Since endothelin production is stimulated in vitro by related with the glucose:insulin ratio that has been coninsulin, we performed this study to evaluate in vivo the sidered as an insulin-sensitivity index and positively relationships between endothelin and insulin plasma with the insulin:C-peptide ratio as hepatic insulin-resistlevels during a glucose load.
Introduction
obtained after a glucose load. Endothelin is a powerful vasoconstrictor peptide produced by endothelial cells in response to stimuli
Patients and methods
that cause vascular derangement; 1,2 moreover, when injected intravenously, it causes a long term
We studied 28 (16 male and 12 female) consecutive increase of arterial pressure. 3, 4 Genes for three dispatients from outward clinic for diagnosis and treattinct endothelins (endothelin-1, endothelin-2 and ment of endocrine and metabolic hypertensive disendothelin-3) have been described, 5 but human ease. All gave their informed consent and the study endothelial cells appear to produce exclusively was approved by the Ethic Committee of Internal endothelin-1 which derives from the 203-aminoMedicine Institute of our University. acid preproendothelin and 92-aminoacid big endoSeventeen were with normal glucose tolerance thelin; thereafter it is converted to the final product (NGT) and 11 with impaired glucose tolerance (IGT) endothelin-1 by the endothelin converting enzyme. 6 as defined by national Diabetes Data Group criTwo different receptors (A and B) for endothelins teria. 12, 13 Ten of the subjects under study were have been found in mammalian cells, but only the normotensive and 18 with mild to moderate hyper-A receptor appears to mediate the vasoconstrictor tension (Table 1) . Secondary hypertension in these effect of these peptides, through the stimulation of patients was excluded by means of clinical examinphospholipase C which leads to the formation of ation and the determination of urinary aldosterone inositol 1,4,5 triphosphate and diacylglycerol. 7 excretion, plasma renin activity and plasma cathecoInsulin, in vitro has a stimulatory effect on the lamines. endothelin-1 production 8 and because increased After at least 2 weeks of washout from drugs, they values of this vasoconstrictor peptide have been underwent a standard oral glucose (75 g) tolerance found in diabetic patients [9] [10] [11] it has been considered test; venous blood was drawn at 0, 90 and 120 min to play a role in the development of hypertension after the load for glucose, immunoreactive insulin, that frequently complicates diabetes mellitus.
C-peptide of insulin and endothelin-1 and -2 deterThe aim of this work is to verify in vivo the minations. changes of plasma endothelin following the physioGlucose was measured by the glucose-oxidase method; insulin and C-peptide of insulin by doubleantibody radioimmunoassays (Incstar Corporation, NGT: normal glucose tolerance; IGT: impaired glucose tolerance; BMI: body mass index; MAP: mean arterial pressure. *P Ͻ 0.05; **P Ͻ 0.02; ***P Ͻ 0.01 hypertensives vs normotensives or IGT vs NGT.
body crossreacts 100% with endothelin-1, 204% with endothelin-2, 0% with synthetic endothelin-3 and 37.9% with human big endothelin-1.
Values are expressed as means ± s.e.m. The results were analysed by one-way analysis of variance with the Bonferroni post hoc correction. For data which appeared not to be normally distributed, the Friedman non-parametric statistic was used to evaluate the effect of the glucose load.
Multiple regression analysis was undertaken with basal endothelin as the dependent variable and blood pressure (BP), body mass index (BMI), blood glucose at 120 min after the glucose load, and basal insulin as independent variable. Rank Spearman's correlation test was also used for the relationship between variables not normally distributed. A value of P Ͻ 0.05 was considered significant. 
Results
On the multivariate regressions, only basal insulin was predictive for basal endothelin (logarithmic computed) (r = 0.37; P Ͻ 0.05; Figure 1) ; whereas BMI, blood glucose at 120 min after the oral glucose load and BP were not related to endothelin as an independent variable. Fasting glucose:insulin ratio and insulin:C-peptide ratio also showed a significant correlation with the basal endothelin (respectively r = −0.42; P Ͻ 0.03; Figure 2 and r = 0.40; P Ͻ 0.03; Figure 3 ).
After the glucose load, endothelin mean plasma levels increased significantly in all the groups of patients (Table 2 ) except those with NGT. The per cent increase of endothelin 2 h after the glucose load was positively correlated with the per cent increase of insulin in the sub-group of hypertensive patients (rho: 0.50; P: 0.034), in the subgroup of patients with impaired glucose tolerance (rho: 0.65; P: 0.020) and when all the subjects under study were considered together (rho: 0.41; P: 0.015). No significant relationship could be found with the plasma glucose increase.
Endothelin values were not significantly different in hypertensive patients in comparison with normo- with those with normal tolerance at any time of the responsive element that could be responsible for this stimulating effect of insulin. 21 glucose load (Table 2 ). No differences in insulin and C-peptide parameters were seen between the groups Wolpert et al 22 and Ferri et al 8 have shown, however, that an acutely induced increase in circulating except for the glucose:insulin ratio that was significantly lower in hypertensives in comparison with insulin is rapidly followed by an increase of plasma endothelin values, suggesting that in this situation the normotensives (Table 2) . this peptide could also be released from cell storage or rapidly produced by endothelial cells. In the
Discussion
experimental design of these works, however, insulin was injected in pharmacological amount and Because of its powerful vasoconstrictor property an involvement of endothelin has been thought possobviously not in a physiological way, whereas we analysed the consequence of an usual insulin rise ible in the development of human hypertension; however only the minority of reports show that can be obtained by oral carbohydrates.
After the glucose load we did not measure the increased circulating levels of endothelin in hypertensive patients, 14,15 whereas more often normal variations of blood flow or of BP, so we do not know if any measurable hemodynamic effect is joined to values of this peptide have been found. [16] [17] [18] Our results confirm no significant difference in plasma the observed endothelin increase. However, we know that a very low concentration of endothelin, endothelin levels between normotensive and hypertensive subjects, but our patients were, however, all even if is not able to produce vasoconstriction, still potentiates the response to other vasoconstrictor free from renal complications that could be a cause of the increased endothelin concentrations reported hormones 23 and the median endothelin increase of about 50% could well obtain these effects. by others.
In our study, moreover, significant differences in Fasting glucose:insulin ratio can be considered as an insulin-sensitivity index; when blood glucose is endothelin values was not found between subjects with NGT and IGT; it is noteworthy, however, that not abnormally increased, a lower ratio indicates that in a basal state more insulin is necessary to none of our patients had overt diabetes.
Our results still show that in all the subjects under maintain optimal glucose metabolism. 13 Similarly, the insulin:C-peptide ratio calculated from a periphstudy, basal plasma endothelin values are correlated with fasting insulin levels and that the increase in eral venous blood sample can be an index of insulin extraction so that a higher value indicates insulin insulin concentration following a standard glucose load is accompanied by a correlated endothelin rise, resistance.
24
Among the subjects that underwent our study, as particularly in hypertensives and in subjects with IGT.
expected hypertensives 25 had a lower basal glucose:insulin ratio in comparison with normotenInsulin stimulated production of endothelin from endothelial cells has been observed in vitro 8, 19, 20 and sives; between subjects with normal and IGT no significant difference was seen for this parameter, it seems to require de novo protein synthesis; preproendothelin-1 promoter contains an insulinperhaps because the high percentage (52.9%) of hypertensives were in the NGT group. 
